Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002520.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 0.54 0.77 0.76
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 44.08 -142.16 98.67
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 6.88 1.58 1.48
Cash -6.68 0.36 0.39
Capex 73.58 -0.02 -0.09
Free Cash Flow 464.09 0.10 0.02
Revenue -20.55 0.59 0.75
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -53.40 0.12 0.26
Operating Margin 94.22 -0.06 -0.99
ROA 96.26 < 0.005 -0.20
ROE 96.24 -0.03 -0.67
ROIC 96.29 -0.01 -0.29
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002520.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002520.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002520.SZ is permitted for members.